ENSURE PLUS HN

Main information

  • Trade name:
  • ENSURE PLUS HN 10 TAB
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENSURE PLUS HN 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

13-4-2018

Ensure the proper use of antiparasitics for the treatment of pets!

Ensure the proper use of antiparasitics for the treatment of pets!

The return of spring is synonymous with that of parasites such as ticks, fleas and mosquitoes that can cause serious diseases in animals as well as diseases transmissible to humans. To protect our domestic animals, the use of ectoparasiticides is an effective solution. These antiparasitics can be used to treat and/or prevent insect infestations in animals. However, it is important to ensure the proper use of these veterinary medicinal products!

France - Agence Nationale du Médicament Vétérinaire

22-3-2018

BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes

BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it is updating the instructions for use of certain BD Vacutainer® tubes as part of its quality process to ensure that customers understand the appropriate uses of these products.

FDA - U.S. Food and Drug Administration

1-3-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts label for foods

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts label for foods

Americans rely on the U.S. Food and Drug Administration to ensure that food labels contain updated nutritional information to help them make more informed food choices that lead to better health for themselves and their families. I’ve made nutrition one of my top priorities, and ensuring that consumers have accurate and science-based information concerning the link between diet and chronic diseases like diabetes, obesity and heart disease is part of that commitment. We need to advance new ways to use the...

FDA - U.S. Food and Drug Administration

8-2-2018

FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

FDA and NRC today took important steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases

FDA - U.S. Food and Drug Administration

2-2-2018

Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure

Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure

One part of the Food and Drug Administration’s mission is to ensure the safety of electronic products that emit radiation, like televisions and cell phones. These types of products are part of Americans’ daily life and we take our duty to protect consumers with the utmost gravity. With cell phones, we have relied extensively on a myriad scientific evidence developed over many years to help inform our regulatory thinking. Although the Federal Communications Commission (FCC) sets the standard for radiofreq...

FDA - U.S. Food and Drug Administration

11-10-2017

Medical Imaging Drugs Advisory Committee Charter

Medical Imaging Drugs Advisory Committee Charter

The Medical Imaging Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.

FDA - U.S. Food and Drug Administration

10-10-2017

Nonprescription Drugs Advisory Committee

Nonprescription Drugs Advisory Committee

he Nonprescription Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.

FDA - U.S. Food and Drug Administration

6-10-2017

Scientific guideline:  Guidance on the classification of veterinary medicinal products indicated for minor use minor species (MUMS) / limited market - Revision 1, adopted

Scientific guideline: Guidance on the classification of veterinary medicinal products indicated for minor use minor species (MUMS) / limited market - Revision 1, adopted

This guideline is based on the Revised Policy for classification and incentives for veterinary medicinal products indicated for minor use minor species (MUMS)/limited market (EMA/308411/2014). This revision (Rev.1) is an administrative update to ensure that the document corresponds with the revised guidelines on data requirements for veterinary medicinal products intended for MUMS/limited market that were adopted by CVMP in 2017. The opportunity has been taken to simplify the request process for applica...

Europe - EFSA - European Food Safety Authority EFSA Journal

26-9-2017

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA actions to bring relief to citizens of Puerto Rico; to help the island recover its considerable and economically vital medical product manufacturing base; and to prevent critical shortages of li

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA actions to bring relief to citizens of Puerto Rico; to help the island recover its considerable and economically vital medical product manufacturing base; and to prevent critical shortages of li

As an agency dedicated to promoting public health, and as fellow Americans, the staff at the U.S. Food and Drug Administration is doing all it can to support the immediate needs of Puerto Ricans following the destruction of Hurricane Maria. First and foremost, these efforts are focused around our mission driven responsibilities to ensure the safety of the medical products, blood and the food supply needed by residents of the island. Our efforts also encompass challenges that are unique to Puerto Rico. Th...

FDA - U.S. Food and Drug Administration

28-8-2017

Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine

Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine

One of the most promising new fields of science and medicine is the area of cell therapies and their use in regenerative medicine. These new technologies, most of which are in early stages of development, hold significant promise for transformative and potentially curative treatments for some of humanity’s most troubling and intractable maladies. Recent advances in our basic knowledge of the pathways involved in tissue damage and regeneration have combined with remarkable progress in adult stem cell biol...

FDA - U.S. Food and Drug Administration

28-7-2017

FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death. The approach places nicotine, and the issue of addiction, at the center of the agency’s tobacco regulation efforts. The goal is to ensure that the FDA has the proper scientific and regulatory foundation to efficiently and effectively implement the Family Smoking Pr...

FDA - U.S. Food and Drug Administration

14-7-2017

 Adverse reaction reports received from the Danish Patient Compensation Association

Adverse reaction reports received from the Danish Patient Compensation Association

The marketing authorisation holder of a medicinal product shall not submit reports to the Danish Medicines Agency about any adverse reactions appearing from decisions about compensation for medicinal injuries, which the company has received from the Danish Patient Compensation Association. Section 6(1) and (2) of the Danish executive order no. 898 of 23 June 2016 on the monitoring of adverse reactions from medicinal products stipulate that the marketing authorisation holder must submit reports to the Da...

Danish Medicines Agency

7-7-2017

 Information meeting in October about new medical device regulations

Information meeting in October about new medical device regulations

The European Commission has adopted and published new EU regulations on medical devices and in vitro diagnostic medical devices. The regulations will apply from May 2020 and May 2022, respectively. The regulations will strengthen patient safety and ensure the availability of new devices, which will be of benefit to patients. The Danish Medicines Agency would like to invite manufacturers of medical devices, importers and distributors of medical devices and other relevant players to a meeting to inform t...

Danish Medicines Agency

29-6-2017

FDA unveils plan to eliminate orphan designation backlog

FDA unveils plan to eliminate orphan designation backlog

Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely response to all new requests for designation with firm deadlines. The agency’s Orphan Drug Modernization Plan comes a week after FDA Commissioner Scott Gottlieb committed to eliminating the backlog within 90 days and responding to all new requests for designation within 90 days of receipt during his testimony before a Senate subcommittee.

FDA - U.S. Food and Drug Administration

15-6-2017

Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results

Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results

While the latest numbers from the 2016 National Youth Tobacco Survey are encouraging, it is critical that we work to ensure this downward trend continues over the long term across all tobacco products. Every day in the U.S., more than 2,500 youth under the age of 18 smoke their first cigarette and more than 400 youth become daily cigarette smokers. It is also clear from these most recent numbers that youth are continuing to experiment with, or becoming regular users of, a wide range of other tobacco pro...

FDA - U.S. Food and Drug Administration

18-12-2006

Reassessment of reimbursement status

Reassessment of reimbursement status

This summer, the Danish Medicines Agency will begin the periodic reassessment of reimbursement status of medicinal products. Over a 5-year period, the reimbursement status of all medicinal products will be reassessed to ensure that the medicinal products having been granted general reimbursement still meet the required criteria and that medicinal products which have not been granted general reimbursement do not meet the criteria.

Danish Medicines Agency

7-4-2018

#DYK today is #WorldHealthDay? A global health awareness day led by @WHO , and other related organizations. Check out how CDRH works with countries from around the world to ensure citizens have access to safe and effective medical devices here in the U.S.

#DYK today is #WorldHealthDay? A global health awareness day led by @WHO , and other related organizations. Check out how CDRH works with countries from around the world to ensure citizens have access to safe and effective medical devices here in the U.S.

#DYK today is #WorldHealthDay? A global health awareness day led by @WHO , and other related organizations. Check out how CDRH works with countries from around the world to ensure citizens have access to safe and effective medical devices here in the U.S. https://go.usa.gov/xQ4K7  pic.twitter.com/0HehLVpwxz

FDA - U.S. Food and Drug Administration

30-1-2018

Jeff Shuren talks #DigitalHealth. FDA develops #FDAPrecert collaboratively to ensure timely access to high-quality, safe and effective DH products

Jeff Shuren talks #DigitalHealth. FDA develops #FDAPrecert collaboratively to ensure timely access to high-quality, safe and effective DH products

Jeff Shuren talks #DigitalHealth. FDA develops #FDAPrecert collaboratively to ensure timely access to high-quality, safe and effective DH products

FDA - U.S. Food and Drug Administration

23-1-2018

News and press releases:  EMA surveys pharma companies on their preparedness for Brexit

News and press releases: EMA surveys pharma companies on their preparedness for Brexit

Planning of regulatory steps needed to ensure medicines remain on EU market

Europe - EMA - European Medicines Agency

24-11-2017

News and press releases:  New guidelines on good manufacturing practices for advanced therapies

News and press releases: New guidelines on good manufacturing practices for advanced therapies

Adaptations ensure a high level of quality for ATMPs and patient protection

Europe - EMA - European Medicines Agency

21-11-2017

Workshops: Codeine up-scheduling

Workshops: Codeine up-scheduling

These sessions are designed to ensure health professionals dealing with chronic and acute pain management have alternative strategies to use in preparation for 1 February and beyond.

Therapeutic Goods Administration - Australia

20-11-2017

News and press releases:  EMA to relocate to Amsterdam, the Netherlands

News and press releases: EMA to relocate to Amsterdam, the Netherlands

Agency to begin working immediately with Dutch government to ensure successful move by end of March 2019

Europe - EMA - European Medicines Agency

16-10-2017

News and press releases:  EMA’s Business Continuity Plan for Brexit published

News and press releases: EMA’s Business Continuity Plan for Brexit published

Plan aims to ensure continuity of Agency’s operations

Europe - EMA - European Medicines Agency

3-10-2017

News and press releases:  EMA publishes comments on Member States’ hosting bids

News and press releases: EMA publishes comments on Member States’ hosting bids

Accessibility for delegates and experts and staff retention are key to ensure Agency’s ability to function

Europe - EMA - European Medicines Agency

21-8-2017

User fees help FDA ensure safe/effective medical products, max regulatory efficiency & advance medical innovation.  https://go.usa.gov/xRwpY pic.twitter.com/aaj8eZ9yni

User fees help FDA ensure safe/effective medical products, max regulatory efficiency & advance medical innovation. https://go.usa.gov/xRwpY pic.twitter.com/aaj8eZ9yni

User fees help FDA ensure safe/effective medical products, max regulatory efficiency & advance medical innovation. https://go.usa.gov/xRwpY  pic.twitter.com/aaj8eZ9yni

FDA - U.S. Food and Drug Administration

19-5-2017

News and press releases:  EMA recommends changes to prescribing information for vancomycin antibiotics

News and press releases: EMA recommends changes to prescribing information for vancomycin antibiotics

Changes aim to ensure appropriate use in context of fight against antimicrobial resistance

Europe - EMA - European Medicines Agency